Company 1 identity field
Location
San Francisco, CA
SEC filing record 1 source field
Fiscal year end
31 December
Vir Biotechnology, Inc. has filed 771 SEC EDGAR filings since 29 Jun 2018

SEC filing history

Showing 526-550 of 771 matching filings.

Per page
25
Current page
22
4

FORM 4 SUBMISSION

Filing date
20 May 2021
Reporting date
19 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 May 2021
Reporting date
18 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 May 2021
Reporting date
04 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Apr 2021
Reporting date
27 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Apr 2021
Reporting date
19 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Apr 2021
Reporting date
16 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Apr 2021
Reporting date
13 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91177

ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(#2)

Filing date
14 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39083

8-K

Filing date
13 Apr 2021
Reporting date
13 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Apr 2021
Reporting date
09 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
09 Apr 2021
Reporting date
07 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
09 Apr 2021
Reporting date
07 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39083

DEFA14A

Filing date
06 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39083

DEF 14A

Filing date
06 Apr 2021
Reporting date
20 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Apr 2021
Reporting date
01 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
01 Apr 2021
Reporting date
30 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
01 Apr 2021
Reporting date
30 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Mar 2021
Reporting date
29 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
31 Mar 2021
Reporting date
29 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39083

8-K

Filing date
31 Mar 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39083

8-K

Filing date
30 Mar 2021
Reporting date
26 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Mar 2021
Reporting date
23 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Mar 2021
Reporting date
10 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .